GlassScriptPhysician profile
Timothy M Straight
NPI 1336139690
$5,558.20
in general payments reported to CMS, 2019-2025
34 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $60.91 · 2021: $449 · 2022: $775 · 2023: $1,184 · 2024: $1,463 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,812.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,315.23 | 2019-2025 | Olumiant, Taltz, Ebglyss |
| Abbvie INC. | $686.85 | 2021-2025 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $419.42 | 2019-2025 | Dupixent |
| Galderma Laboratories, L.P. | $357.99 | 2020-2025 | Nemluvio |
| Ucb, INC. | $289.90 | 2024-2025 | Bimzelx |
| Biofrontera INC. | $264.50 | 2021-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Biocompatibles, INC. | $255.17 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $235.34 | 2023-2024 | Cabtreo, Arazlo |
| Pfizer INC. | $225.75 | 2023-2025 | |
| Revance Therapeutics, INC. | $211.42 | 2024 | Daxi, Daxxify |
| Organon LLC | $176.88 | 2025 | Vtama |
| Dermavant Sciences, INC. | $166.62 | 2022-2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.10 | 2023 | Spevigo |
| Kyowa Kirin, INC. | $118.21 | 2024 | Poteligeo |
| Sun Pharmaceutical Industries INC. | $116.60 | 2021-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $98.97 | 2021-2025 | Opzelura |
| Almirall LLC | $86.78 | 2022-2024 | Klisyri, Seysara |
| Krystal Biotech INC | $61.45 | 2023-2025 | Vyjuvek |
| Verrica Pharmaceuticals INC. | $42.14 | 2024-2025 | Ycanth |
| Tactile Systems Technology INC | $29.38 | 2020-2021 | |
| Medtronic, INC. | $28.82 | 2022 | |
| Bard Peripheral Vascular, INC. | $27.53 | 2025 | Venclose Maven Catheter |
| Novartis Pharmaceuticals Corporation | $23.44 | 2024 | |
| Arcutis Biotherapeutics, INC. | $22.96 | 2025 | Zoryve |
| Janssen Biotech, INC. | $21.42 | 2025 | Tremfya |
| Medline Industries LP | $20.43 | 2022 | |
| Leo Pharma INC. | $18.87 | 2021 | |
| Sensus Healthcare, INC. | $18.01 | 2024 | |
| Genzyme Corporation | $17.89 | 2025 | |
| Resmed Corp | $17.59 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $17.29 | 2022 | |
| Botanix Sb INC | $16.05 | 2025 | Sofdra |
| E.R. Squibb & Sons, L.L.C. | $13.68 | 2023 | Sotyktu |
| Boston Scientific Corporation | $13.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Straight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.